Cytokinetics

CYTKNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.392 B

$67.56 -1.77%

Close of 21 Sept 2026

Revenue

$88.0M

#2545 by revenue

Earnings

-$785.0M

Loss-making

Shares outstanding

139,023,418

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#34Dr Reddys LaboratoriesRDY$10.3B
#35Arrowhead PharmaceuticalsARWR$9.72B
#36CytokineticsCYTK$9.39B
#37Protagonist TherapeuticsPTGX$9.38B
#38AbivaxABVX$8.91B

What if Cytokinetics were worth as much as…

Open the what-if tool →

Gold $30.3T

$217,762.26

Per share 3,223× higher

Bitcoin $1.72T

$12,370.60

Per share 183× higher

Nvidia $5.48T

$39,416.80

Per share 583× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Cytokinetics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.